You are here : Home > News > CEA Tech to exhibit at CES 2019

CES 2019 : CEA Tech to exhibit at CES Las Vegas on January 8–11

Digitalization of healthcare

DIABELOOP: Artificial pancreas for type-1 diabetics.

Published on 15 January 2019


Comprehensive and personalized system for autonomous T1D management

Diabeloop is a French independent company developing disruptive technological innovations to automate the treatment of Type one diabetes.

 Its first product, the DBLG1 System, is an integrated system that allows glycemic control in an automatic and highly efficient way. The core of this innovation is an Artificial Intelligence hosted on a terminal that connects via bluetooth with a continuous glucose meter (CGM) and an insulin pump.

 The algorithm makes and executes the many therapeutic decisions that the patients currently have to handle by themselves. Patients are only expected to log meals and physical activities. 


  • Target markets:

• E-healthcare
• Medical devices
• Therapeutic innovation
• Artificial intelligence